These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25939993)

  • 1. Impact of common functional polymorphisms in renin angiotensin system genes on the risk of renal parenchymal scarring following childhood urinary tract infection.
    Hussein A; Elderwy AA; Askar E; Afifi N; Askar G; Metwalley KA; Alsaeid M
    J Pediatr Urol; 2015 Jun; 11(3):152.e1-7. PubMed ID: 25939993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection.
    Hussein A; Askar E; Elsaeid M; Schaefer F
    Nephrol Dial Transplant; 2010 Mar; 25(3):779-85. PubMed ID: 19861314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE gene polymorphism and renal scarring in primary vesicoureteric reflux.
    Haszon I; Friedman AL; Papp F; Bereczki C; Baji S; Bodrogi T; Károly E; Endreffy E; Túri S
    Pediatr Nephrol; 2002 Dec; 17(12):1027-31. PubMed ID: 12478352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the angiotensin converting enzyme and angiotensin II type 1 receptor genes and renal scarring in non-uropathic children with recurrent urinary tract infection.
    Ece A; Tekes S; Gürkan F; Bilici M; Budak T
    Nephrology (Carlton); 2005 Aug; 10(4):377-81. PubMed ID: 16109085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system polymorphisms and renal scarring.
    Pardo R; Málaga S; Coto E; Navarro M; Alvarez V; Espinosa L; Alvarez R; Vallo A; Loris C; Braga S
    Pediatr Nephrol; 2003 Feb; 18(2):110-4. PubMed ID: 12579398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cytokine genetic polymorphisms on the risk of renal parenchymal infection in children.
    Hussein A; Askar E; Badawy A; Saad K; Zahran A; Elderwy AA
    J Pediatr Urol; 2017 Dec; 13(6):593.e1-593.e10. PubMed ID: 28716390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACE gene polymorphism and renal scarring in children with urinary tract infection and vesicoureteric reflux: preliminary results].
    Kowalewska-Pietrzak M; Młynarski W; Młodkowska E; Kozłowski J; Kubryn I; Gadzicki M; Bodalski J
    Pol Merkur Lekarski; 2003 Feb; 14(80):102-5. PubMed ID: 12728665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is ACE gene polymorphism a risk factor for renal scarring with low-grade reflux?
    Erdoğan H; Mir S; Serdaroğlu E; Berdeli A; Aksu N
    Pediatr Nephrol; 2004 Jul; 19(7):734-7. PubMed ID: 15138870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
    Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE gene polymorphism and renal scar in children with acute pyelonephritis.
    Cho SJ; Lee SJ
    Pediatr Nephrol; 2002 Jul; 17(7):491-5. PubMed ID: 12172760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a five-year study of 99mTc DMSA renal scintigraphy in children and adolescents following acute pyelonephritis.
    Chroustová D; Palyzová D; Urbanová I; Kolská M
    Nucl Med Rev Cent East Eur; 2006; 9(1):46-50. PubMed ID: 16791804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux.
    Liu KP; Lin CY; Chen HJ; Wei CF; Lee-Chen GJ
    Pediatr Nephrol; 2004 Jun; 19(6):594-601. PubMed ID: 15045574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the TNF-alpha and ACE genes, and renal scarring in infants with urinary tract infection.
    Savvidou A; Bitsori M; Choumerianou DM; Karatzi M; Kalmanti M; Galanakis E
    J Urol; 2010 Feb; 183(2):684-7. PubMed ID: 20022049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection.
    Lin KY; Chiu NT; Chen MJ; Lai CH; Huang JJ; Wang YT; Chiou YY
    Pediatr Nephrol; 2003 Apr; 18(4):362-5. PubMed ID: 12700963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of pentraxin-3 correlates with the presence of renal scar following acute pyelonephritis in children.
    Becerir T; Yüksel S; Evrengül H; Ergin A; Enli Y
    Int Urol Nephrol; 2019 Apr; 51(4):571-577. PubMed ID: 30796728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
    Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J
    Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicoureteral Reflux and Renal Scarring in Infants After the First Febrile Urinary Tract Infection.
    Pokrajac D; Sefic-Pasic I; Begic A
    Med Arch; 2018 Oct; 72(4):272-275. PubMed ID: 30514993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney length and scarring in children with urinary tract infection: importance of ultrasound scans.
    Peratoner L; Pennesi M; Bordugo A; Melega R; Sorce P; Travan L; Minisini S; Zennaro F; Da Ronch L
    Abdom Imaging; 2005; 30(6):780-5. PubMed ID: 16252147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First episode of febrile urinary tract infection in children, detection and risk factors of kidney scarring: A prospective cohort study.
    Tramma D; Dokousli V; Samourkasidou D; Gkiourtzis N
    Clin Nephrol; 2024 Jul; 102():16-24. PubMed ID: 38726574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A supplementation is effective for improving the clinical symptoms of urinary tract infections and reducing renal scarring in girls with acute pyelonephritis: a randomized, double-blind placebo-controlled, clinical trial study.
    Kahbazi M; Sharafkhah M; Yousefichaijan P; Taherahmadi H; Rafiei M; Kaviani P; Abaszadeh S; Massoudifar A; Mohammadbeigi A
    Complement Ther Med; 2019 Feb; 42():429-437. PubMed ID: 30670279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.